The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-benzylidene-2-[(2,4-dioxo-1H-pyrimidin-6-yl)methylsulfanyl]-4-phenyl-5,6-dihydrocyclopenta[b]pyridine-3-carbonitrile ID: ALA4564205
PubChem CID: 56698596
Max Phase: Preclinical
Molecular Formula: C27H20N4O2S
Molecular Weight: 464.55
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: N#Cc1c(SCc2cc(=O)[nH]c(=O)[nH]2)nc2c(c1-c1ccccc1)CC/C2=C\c1ccccc1
Standard InChI: InChI=1S/C27H20N4O2S/c28-15-22-24(18-9-5-2-6-10-18)21-12-11-19(13-17-7-3-1-4-8-17)25(21)31-26(22)34-16-20-14-23(32)30-27(33)29-20/h1-10,13-14H,11-12,16H2,(H2,29,30,32,33)/b19-13+
Standard InChI Key: ORXIWFKVGQVCOG-CPNJWEJPSA-N
Molfile:
RDKit 2D
34 38 0 0 0 0 0 0 0 0999 V2000
6.8527 -11.6459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5662 -11.2313 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.2799 -11.6453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2799 -12.4711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5687 -12.8807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8527 -12.4722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1395 -12.8870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4262 -13.2976 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5687 -13.7061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2818 -14.1171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2807 -14.9431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5672 -15.3539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8580 -14.9440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8511 -14.1193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0619 -12.7143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5572 -12.0472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0840 -11.3959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2976 -10.5982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0953 -10.3845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3093 -9.5868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1039 -9.3752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6841 -9.9595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4742 -10.7521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6789 -10.9681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1395 -11.2311 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.4262 -11.6459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7088 -11.2311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9957 -11.6459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2825 -11.2311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2825 -10.4098 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9957 -9.9950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7088 -10.4098 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9957 -9.1696 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5692 -11.6459 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
6 7 1 0
7 8 3 0
9 5 1 0
10 9 2 0
11 10 1 0
12 11 2 0
13 12 1 0
14 13 2 0
9 14 1 0
4 15 1 0
15 16 1 0
17 16 1 0
3 17 1 0
17 18 2 0
18 19 1 0
20 19 2 0
21 20 1 0
22 21 2 0
23 22 1 0
24 23 2 0
19 24 1 0
1 25 1 0
25 26 1 0
26 27 1 0
28 27 2 0
29 28 1 0
30 29 1 0
31 30 1 0
32 31 1 0
27 32 1 0
31 33 2 0
29 34 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 464.55Molecular Weight (Monoisotopic): 464.1307AlogP: 4.78#Rotatable Bonds: 5Polar Surface Area: 102.40Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.75CX Basic pKa: 0.17CX LogP: 5.12CX LogD: 5.10Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.41Np Likeness Score: -1.05
References 1. (2017) Arf6 inhibitors and methods of synthesis and use thereof,